South Korea’s pharma industry has a valuable pool of promising drugs, but China still leads the way in out-licensing deals.

Cambridge-based Biogen is looking to the growth of its Alzheimer’s drug Leqembi to offset the decline of its multiple ...

The Texas attorney general’s office stated that Eli Lilly allegedly bribed and illegally induced medical providers to prescribe its most profitable drugs. The lawsuit specifically mentions the company ...

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Eli Lilly wasn’t one of them. The 10 stocks that made the cut could ...

WASHINGTON (Reuters) -Texas Attorney General Ken Paxton on Tuesday sued U.S. drugmaker Eli Lilly for allegedly "bribing" ...